BIOMARKER:

TNFRSF8 expression

Entrez ID:

Related biomarkers:

‹

›

TNFRSF8 expression TNFRSF8 expression	Peripheral T-cell Lymphoma Peripheral T-cell Lymphoma	TNFRSF8 expression TNFRSF8 expression	Peripheral T-cell Lymphoma Peripheral T-cell Lymphoma	brentuximab vedotin Sensitive: A1 - Approval	brentuximab vedotin Sensitive: A1 - Approval
TNFRSF8 expression TNFRSF8 expression	T Cell Non-Hodgkin Lymphoma T Cell Non-Hodgkin Lymphoma	TNFRSF8 expression TNFRSF8 expression	T Cell Non-Hodgkin Lymphoma T Cell Non-Hodgkin Lymphoma	brentuximab vedotin Sensitive: B - Late Trials	brentuximab vedotin Sensitive: B - Late Trials
TNFRSF8 expression TNFRSF8 expression	Acute Myelogenous Leukemia AML	TNFRSF8 expression TNFRSF8 expression	Acute Myelogenous Leukemia AML	brentuximab vedotin Sensitive: C1 - Off-label	brentuximab vedotin Sensitive: C1 - Off-label
TNFRSF8 expression TNFRSF8 expression	Cutaneous T-cell Lymphoma Cutaneous T-cell Lymphoma	TNFRSF8 expression TNFRSF8 expression	Cutaneous T-cell Lymphoma Cutaneous T-cell Lymphoma	brentuximab vedotin Sensitive: C1 - Off-label	brentuximab vedotin Sensitive: C1 - Off-label
TNFRSF8 expression TNFRSF8 expression	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	TNFRSF8 expression TNFRSF8 expression	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	rituximab + brentuximab vedotin Sensitive: C3 – Early Trials	rituximab + brentuximab vedotin Sensitive: C3 – Early Trials
TNFRSF8 expression TNFRSF8 expression	Peripheral T-cell Lymphoma Peripheral T-cell Lymphoma	TNFRSF8 expression TNFRSF8 expression	Peripheral T-cell Lymphoma Peripheral T-cell Lymphoma	CHEP-BV Sensitive: C3 – Early Trials	CHEP-BV Sensitive: C3 – Early Trials